FindTrial
Sign In

Role of Perioperative Transcutaneous Electrical Acupoint Stimulation in Enhanced Recovery After Thoracoscopic Surgery

Role of Perioperative Transcutaneous Electrical Acupoint Stimulation in Enhanced Recovery After Thoracoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001883
Enrollment
Unknown
Registered
2025-10-11
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enhanced Recovery after Thoracoscopic Surgery

Interventions

Transcutaneous Electrical Acupoint Stimulation Group:Thirty minutes before anesthesia induction, bilateral Dazhu (BL11), Fengmen (BL12), and Feishu (BL13) acupoints were selected for transcutaneous el
Sham Treatment Group:Thirty minutes before anesthesia induction, electrode pads were attached at bilateral Dazhu (BL11), Fengmen (BL12), and Feishu (BL13) acupoints, but no current stimulation was app

Sponsors

Japan-China Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective thoracoscopic surgery and receiving acupuncture-assisted anesthesia for the first time. 2. American Society of Anesthesiologists (ASA) physical status classification Grade I-II. 3. Aged 18-70 years. 4. Body Mass Index (BMI) ranging from 18 to 25 kg/m². 5. No significant abnormalities in liver function, renal function, coagulation function, or albumin level. 6. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone surgery on the meridian lines where the selected acupoints are located. 2. Patients with local skin infection at the acupoint sites. 3. Patients with upper or lower limb nerve injury. 4. Patients who have participated in other clinical trials within the past 4 weeks. 5. Patients unable to cooperate with the completion of the research process. 6. Patients with an implanted cardiac pacemaker. 7. Patients requiring conversion to open thoracic surgery during the operation.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;Visual Analog Scale;—

Secondary

MeasureTime frame
Postoperative Quality of Recovery-15;Neutrophil Elastase;Clara Cell Protein 16;Tumor Necrosis Factor-alpha;Interleukin-10;Incidence of Pulmonary Complications;Length of Hospital Stay;Extubation Time of Thoracic Drainage Tube;Consumption of Opioid Drug;Recovery Time;Dosage of Vasoactive Drugs;—

Countries

China

Contacts

Public ContactWeixia Li

Japan-China Friendship Hospital

liweixia12@126.com13810102697

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026